1. Home
  2. GTBP vs DGLY Comparison

GTBP vs DGLY Comparison

Compare GTBP & DGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GTBP
  • DGLY
  • Stock Information
  • Founded
  • GTBP 1965
  • DGLY 2004
  • Country
  • GTBP United States
  • DGLY United States
  • Employees
  • GTBP N/A
  • DGLY N/A
  • Industry
  • GTBP Biotechnology: Pharmaceutical Preparations
  • DGLY Radio And Television Broadcasting And Communications Equipment
  • Sector
  • GTBP Health Care
  • DGLY Technology
  • Exchange
  • GTBP Nasdaq
  • DGLY Nasdaq
  • Market Cap
  • GTBP 2.6M
  • DGLY 2.8M
  • IPO Year
  • GTBP N/A
  • DGLY N/A
  • Fundamental
  • Price
  • GTBP $0.74
  • DGLY $1.25
  • Analyst Decision
  • GTBP Strong Buy
  • DGLY
  • Analyst Count
  • GTBP 1
  • DGLY 0
  • Target Price
  • GTBP $11.00
  • DGLY N/A
  • AVG Volume (30 Days)
  • GTBP 1.2M
  • DGLY 39.9K
  • Earning Date
  • GTBP 11-14-2025
  • DGLY 12-29-2025
  • Dividend Yield
  • GTBP N/A
  • DGLY N/A
  • EPS Growth
  • GTBP N/A
  • DGLY N/A
  • EPS
  • GTBP N/A
  • DGLY N/A
  • Revenue
  • GTBP N/A
  • DGLY $19,097,965.00
  • Revenue This Year
  • GTBP N/A
  • DGLY N/A
  • Revenue Next Year
  • GTBP N/A
  • DGLY $7.38
  • P/E Ratio
  • GTBP N/A
  • DGLY N/A
  • Revenue Growth
  • GTBP N/A
  • DGLY N/A
  • 52 Week Low
  • GTBP $0.54
  • DGLY $1.08
  • 52 Week High
  • GTBP $4.10
  • DGLY $1,960.00
  • Technical
  • Relative Strength Index (RSI)
  • GTBP 53.14
  • DGLY 24.18
  • Support Level
  • GTBP $0.62
  • DGLY $1.20
  • Resistance Level
  • GTBP $1.15
  • DGLY $1.34
  • Average True Range (ATR)
  • GTBP 0.09
  • DGLY 0.10
  • MACD
  • GTBP 0.01
  • DGLY -0.03
  • Stochastic Oscillator
  • GTBP 34.74
  • DGLY 22.76

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

About DGLY Digital Ally Inc.

Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.

Share on Social Networks: